Exodus Point Capital Management, LP Immunome Inc. Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Immunome Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 81,873 shares of IMNM stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
81,873
Previous 102,153
19.85%
Holding current value
$1.13 Million
Previous $687,000
10.77%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IMNM
# of Institutions
148Shares Held
66.5MCall Options Held
44.9KPut Options Held
4.24M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.28MShares$114 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.87MShares$67.4 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$64.8 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$62.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$56.4 Million3.27% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $168M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...